Prostate Cancer UK appoints Dr David Montgomery to lead our research programme by bringing his experience in medicine and the pharmaceutical industry to help ensure that men get the benefits of breakthroughs in the lab as soon as possible.
BLOG: Ahead of the Budget announcement on 29 October, our chief executive Angela Culhane explains why now is the time to really crack earlier diagnosis of the most common cancer in men and the key investments needed to make sure it happens.
BLOG: Dr Ian Le Guillou looks back at some of 2017's highlights from the world of prostate cancer research – all of which we had a hand in bringing about thanks to your generous donations.
Researchers at the Institute of Cancer Research have created a powerful new three-in-one blood test, which could help doctors monitor whether a treatment is working and how a man's cancer is responding. We examine the results and find out why it's another step in the creation of targeted treatments for prostate cancer.
Charles Packshaw joins us to head up our Board of Trustees after a 30-year career in the City of London. He tells us why the appointment means so much to him personally and how he intends to break his PB at his next cycling fundraiser for us.
BLOG: It's been 12 months since we launched our ambitious plan to halve prostate cancer deaths in a decade, and we’ve already taken some huge steps towards our goal. Our chief executive, Angela Culhane, reflects on the progress we’ve made and the exciting work still to come.
We welcome today's reports of a new test by scientists at the University of East Anglia to determine whether a prostate cancer is aggressive or not, but the tell-tale pattern of 45 specific genes hasn't yet been proven to work for all men.
Boxer David Haye, Chuka Umunna MP and Olympic medallist Linford Christie are among the black celebrities leading the charge in a major new awareness drive by Prostate Cancer UK to alert black men about their increased risk of the most common cancer in men.
With the support of the Movember Foundation, we're funding four PhD students in the crucial field of bioinformatics, using big data to help accelerate our understanding and treatment of prostate cancer.
From stem cells to bacterial infections, our £2.6 million Research Innovation Awards will fund eight potentially game-changing research projects into our understanding and treatment of prostate cancer to help us meet our ambitious aim of taming the disease within a decade.